Companies › TRAW
Traws Pharma Inc (TRAW)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001130598 · EDGAR filings · Updated 2026-07-16
Traws Pharma Inc (TRAW) has reported institutional ownership of 35.6%, with 27 institutional managers holding positions valued at $6.62M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-16 — Insider transaction reported (Form 4)
- 2026-07-15 — Insider transaction reported (Form 4)
- 2026-07-15 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
- 2026-07-14 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Traws Pharma Inc has 27 institutional holders and institutional ownership of 35.6%.
Insider activity
Insiders reported 10 transactions (0 buys, 0 sells) across 9 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
TEVOGEN BIO HOLDINGS INC (TVGN) · Lite Strategy Inc (LITS) · DarioHealth Corp (DRIO) · HARVARD BIOSCIENCE INC (HBIO) · Atossa Therapeutics Inc (ATOS) · MEDICUS PHARMA LTD (MDCX)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.